Global Chronic Liver Diseases Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 920132 | Published Date: Apr 2024 | No. of Page: 116 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chemotherapy Drugs
        1.2.3 Targeted Therapy
        1.2.4 Vaccines
        1.2.5 Antiviral Drugs
        1.2.6 Immunoglobulins
        1.2.7 Corticosteroids
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Chronic Liver Diseases Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Chronic Liver Diseases Therapeutics Market Perspective (2016-2027)
    2.2 Chronic Liver Diseases Therapeutics Growth Trends by Regions
        2.2.1 Chronic Liver Diseases Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Chronic Liver Diseases Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Chronic Liver Diseases Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Chronic Liver Diseases Therapeutics Industry Dynamic
        2.3.1 Chronic Liver Diseases Therapeutics Market Trends
        2.3.2 Chronic Liver Diseases Therapeutics Market Drivers
        2.3.3 Chronic Liver Diseases Therapeutics Market Challenges
        2.3.4 Chronic Liver Diseases Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue
        3.1.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Chronic Liver Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Chronic Liver Diseases Therapeutics Revenue
    3.4 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio
        3.4.1 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Liver Diseases Therapeutics Revenue in 2020
    3.5 Chronic Liver Diseases Therapeutics Key Players Head office and Area Served
    3.6 Key Players Chronic Liver Diseases Therapeutics Product Solution and Service
    3.7 Date of Enter into Chronic Liver Diseases Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Liver Diseases Therapeutics Breakdown Data by Type
    4.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2022-2027)

5 Chronic Liver Diseases Therapeutics Breakdown Data by Application
    5.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Chronic Liver Diseases Therapeutics Market Size (2016-2027)
    6.2 North America Chronic Liver Diseases Therapeutics Market Size by Type
        6.2.1 North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
    6.3 North America Chronic Liver Diseases Therapeutics Market Size by Application
        6.3.1 North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
    6.4 North America Chronic Liver Diseases Therapeutics Market Size by Country
        6.4.1 North America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Chronic Liver Diseases Therapeutics Market Size (2016-2027)
    7.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type
        7.2.1 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application
        7.3.1 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Chronic Liver Diseases Therapeutics Market Size by Country
        7.4.1 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Chronic Liver Diseases Therapeutics Market Size (2016-2027)
    9.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type
        9.2.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Application
        9.3.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Chronic Liver Diseases Therapeutics Market Size by Country
        9.4.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Astellas Pharma
        11.1.1 Astellas Pharma Company Details
        11.1.2 Astellas Pharma Business Overview
        11.1.3 Astellas Pharma Chronic Liver Diseases Therapeutics Introduction
        11.1.4 Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.1.5 Astellas Pharma Recent Development
    11.2 Bristol-Myers Squibb
        11.2.1 Bristol-Myers Squibb Company Details
        11.2.2 Bristol-Myers Squibb Business Overview
        11.2.3 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Introduction
        11.2.4 Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.2.5 Bristol-Myers Squibb Recent Development
    11.3 Gilead Sciences
        11.3.1 Gilead Sciences Company Details
        11.3.2 Gilead Sciences Business Overview
        11.3.3 Gilead Sciences Chronic Liver Diseases Therapeutics Introduction
        11.3.4 Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.3.5 Gilead Sciences Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Details
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Chronic Liver Diseases Therapeutics Introduction
        11.4.4 GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 F. Hoffmann-La Roche
        11.5.1 F. Hoffmann-La Roche Company Details
        11.5.2 F. Hoffmann-La Roche Business Overview
        11.5.3 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Introduction
        11.5.4 F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.5.5 F. Hoffmann-La Roche Recent Development
    11.6 Merck
        11.6.1 Merck Company Details
        11.6.2 Merck Business Overview
        11.6.3 Merck Chronic Liver Diseases Therapeutics Introduction
        11.6.4 Merck Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.6.5 Merck Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Chronic Liver Diseases Therapeutics Introduction
        11.7.4 Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.7.5 Novartis Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Chronic Liver Diseases Therapeutics Introduction
        11.8.4 Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.8.5 Sanofi Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Chronic Liver Diseases Therapeutics Introduction
        11.9.4 Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 Takeda Pharmaceutical
        11.10.1 Takeda Pharmaceutical Company Details
        11.10.2 Takeda Pharmaceutical Business Overview
        11.10.3 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Introduction
        11.10.4 Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.10.5 Takeda Pharmaceutical Recent Development
    11.11 Bausch Health
        11.11.1 Bausch Health Company Details
        11.11.2 Bausch Health Business Overview
        11.11.3 Bausch Health Chronic Liver Diseases Therapeutics Introduction
        11.11.4 Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.11.5 Bausch Health Recent Development
    11.12 Theratechnologies
        11.12.1 Theratechnologies Company Details
        11.12.2 Theratechnologies Business Overview
        11.12.3 Theratechnologies Chronic Liver Diseases Therapeutics Introduction
        11.12.4 Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.12.5 Theratechnologies Recent Development
    11.13 Alnylam Pharmaceuticals
        11.13.1 Alnylam Pharmaceuticals Company Details
        11.13.2 Alnylam Pharmaceuticals Business Overview
        11.13.3 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction
        11.13.4 Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.13.5 Alnylam Pharmaceuticals Recent Development
    11.14 Protagonist Therapeutics
        11.14.1 Protagonist Therapeutics Company Details
        11.14.2 Protagonist Therapeutics Business Overview
        11.14.3 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Introduction
        11.14.4 Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.14.5 Protagonist Therapeutics Recent Development
    11.15 Dicerna Pharmaceuticals
        11.15.1 Dicerna Pharmaceuticals Company Details
        11.15.2 Dicerna Pharmaceuticals Business Overview
        11.15.3 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction
        11.15.4 Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.15.5 Dicerna Pharmaceuticals Recent Development
    11.16 Endo International
        11.16.1 Endo International Company Details
        11.16.2 Endo International Business Overview
        11.16.3 Endo International Chronic Liver Diseases Therapeutics Introduction
        11.16.4 Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.16.5 Endo International Recent Development
    11.17 Provectus Biopharmaceuticals
        11.17.1 Provectus Biopharmaceuticals Company Details
        11.17.2 Provectus Biopharmaceuticals Business Overview
        11.17.3 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Introduction
        11.17.4 Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.17.5 Provectus Biopharmaceuticals Recent Development
    11.18 MAX BioPharma
        11.18.1 MAX BioPharma Company Details
        11.18.2 MAX BioPharma Business Overview
        11.18.3 MAX BioPharma Chronic Liver Diseases Therapeutics Introduction
        11.18.4 MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
        11.18.5 MAX BioPharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemotherapy Drugs
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Vaccines
    Table 5. Key Players of Antiviral Drugs
    Table 6. Key Players of Immunoglobulins
    Table 7. Key Players of Corticosteroids
    Table 8. Key Players of Others
    Table 9. Global Chronic Liver Diseases Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Chronic Liver Diseases Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Chronic Liver Diseases Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2016-2021)
    Table 13. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2022-2027)
    Table 15. Chronic Liver Diseases Therapeutics Market Trends
    Table 16. Chronic Liver Diseases Therapeutics Market Drivers
    Table 17. Chronic Liver Diseases Therapeutics Market Challenges
    Table 18. Chronic Liver Diseases Therapeutics Market Restraints
    Table 19. Global Chronic Liver Diseases Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Chronic Liver Diseases Therapeutics Market Share by Players (2016-2021)
    Table 21. Global Top Chronic Liver Diseases Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2020)
    Table 22. Ranking of Global Top Chronic Liver Diseases Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Chronic Liver Diseases Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Chronic Liver Diseases Therapeutics Product Solution and Service
    Table 26. Date of Enter into Chronic Liver Diseases Therapeutics Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2016-2021)
    Table 30. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Chronic Liver Diseases Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Application (2016-2021)
    Table 34. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Astellas Pharma Company Details
    Table 67. Astellas Pharma Business Overview
    Table 68. Astellas Pharma Chronic Liver Diseases Therapeutics Product
    Table 69. Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 70. Astellas Pharma Recent Development
    Table 71. Bristol-Myers Squibb Company Details
    Table 72. Bristol-Myers Squibb Business Overview
    Table 73. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product
    Table 74. Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 75. Bristol-Myers Squibb Recent Development
    Table 76. Gilead Sciences Company Details
    Table 77. Gilead Sciences Business Overview
    Table 78. Gilead Sciences Chronic Liver Diseases Therapeutics Product
    Table 79. Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 80. Gilead Sciences Recent Development
    Table 81. GlaxoSmithKline Company Details
    Table 82. GlaxoSmithKline Business Overview
    Table 83. GlaxoSmithKline Chronic Liver Diseases Therapeutics Product
    Table 84. GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 85. GlaxoSmithKline Recent Development
    Table 86. F. Hoffmann-La Roche Company Details
    Table 87. F. Hoffmann-La Roche Business Overview
    Table 88. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product
    Table 89. F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 90. F. Hoffmann-La Roche Recent Development
    Table 91. Merck Company Details
    Table 92. Merck Business Overview
    Table 93. Merck Chronic Liver Diseases Therapeutics Product
    Table 94. Merck Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 95. Merck Recent Development
    Table 96. Novartis Company Details
    Table 97. Novartis Business Overview
    Table 98. Novartis Chronic Liver Diseases Therapeutics Product
    Table 99. Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Novartis Recent Development
    Table 101. Sanofi Company Details
    Table 102. Sanofi Business Overview
    Table 103. Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 104. Sanofi Recent Development
    Table 105. Pfizer Company Details
    Table 106. Pfizer Business Overview
    Table 107. Pfizer Chronic Liver Diseases Therapeutics Product
    Table 108. Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 109. Pfizer Recent Development
    Table 110. Takeda Pharmaceutical Company Details
    Table 111. Takeda Pharmaceutical Business Overview
    Table 112. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product
    Table 113. Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 114. Takeda Pharmaceutical Recent Development
    Table 115. Bausch Health Company Details
    Table 116. Bausch Health Business Overview
    Table 117. Bausch Health Chronic Liver Diseases Therapeutics Product
    Table 118. Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 119. Bausch Health Recent Development
    Table 120. Theratechnologies Company Details
    Table 121. Theratechnologies Business Overview
    Table 122. Theratechnologies Chronic Liver Diseases Therapeutics Product
    Table 123. Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 124. Theratechnologies Recent Development
    Table 125. Alnylam Pharmaceuticals Company Details
    Table 126. Alnylam Pharmaceuticals Business Overview
    Table 127. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product
    Table 128. Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 129. Alnylam Pharmaceuticals Recent Development
    Table 130. Protagonist Therapeutics Company Details
    Table 131. Protagonist Therapeutics Business Overview
    Table 132. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product
    Table 133. Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 134. Protagonist Therapeutics Recent Development
    Table 135. Dicerna Pharmaceuticals Company Details
    Table 136. Dicerna Pharmaceuticals Business Overview
    Table 137. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product
    Table 138. Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 139. Dicerna Pharmaceuticals Recent Development
    Table 140. Endo International Company Details
    Table 141. Endo International Business Overview
    Table 142. Endo International Chronic Liver Diseases Therapeutics Product
    Table 143. Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 144. Endo International Recent Development
    Table 145. Provectus Biopharmaceuticals Company Details
    Table 146. Provectus Biopharmaceuticals Business Overview
    Table 147. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product
    Table 148. Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 149. Provectus Biopharmaceuticals Recent Development
    Table 150. MAX BioPharma Company Details
    Table 151. MAX BioPharma Business Overview
    Table 152. MAX BioPharma Chronic Liver Diseases Therapeutics Product
    Table 153. MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
    Table 154. MAX BioPharma Recent Development
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Liver Diseases Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Chemotherapy Drugs Features
    Figure 3. Targeted Therapy Features
    Figure 4. Vaccines Features
    Figure 5. Antiviral Drugs Features
    Figure 6. Immunoglobulins Features
    Figure 7. Corticosteroids Features
    Figure 8. Others Features
    Figure 9. Global Chronic Liver Diseases Therapeutics Market Share by Application: 2020 VS 2027
    Figure 10. Hospital Pharmacies Case Studies
    Figure 11. Retail Pharmacies Case Studies
    Figure 12. Online Pharmacies Case Studies
    Figure 13. Chronic Liver Diseases Therapeutics Report Years Considered
    Figure 14. Global Chronic Liver Diseases Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global Chronic Liver Diseases Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Chronic Liver Diseases Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 17. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2022-2027)
    Figure 18. Global Chronic Liver Diseases Therapeutics Market Share by Players in 2020
    Figure 19. Global Top Chronic Liver Diseases Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by Chronic Liver Diseases Therapeutics Revenue in 2020
    Figure 21. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 22. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 23. North America Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
    Figure 25. North America Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
    Figure 26. North America Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
    Figure 27. United States Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
    Figure 31. Europe Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
    Figure 32. Europe Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
    Figure 33. Germany Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Region (2016-2027)
    Figure 43. China Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
    Figure 51. Latin America Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
    Figure 52. Latin America Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
    Figure 53. Mexico Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
    Figure 59. Turkey Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Astellas Pharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 64. Gilead Sciences Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 67. Merck Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 68. Novartis Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 69. Sanofi Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 71. Takeda Pharmaceutical Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 72. Bausch Health Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 73. Theratechnologies Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 74. Alnylam Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 75. Protagonist Therapeutics Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 76. Dicerna Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 77. Endo International Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 78. Provectus Biopharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 79. MAX BioPharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astellas Pharma
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
F. Hoffmann-La Roche
Merck
Novartis
Sanofi
Pfizer
Takeda Pharmaceutical
Bausch Health
Theratechnologies
Alnylam Pharmaceuticals
Protagonist Therapeutics
Dicerna Pharmaceuticals
Endo International
Provectus Biopharmaceuticals
MAX BioPharma
Frequently Asked Questions
Chronic Liver Diseases Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Liver Diseases Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Liver Diseases Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports